DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Targeted Chemo-elimination (TCE) of Malaria

Not Applicable

Completed

Conditions: Plasmodium Falciparum Malaria

Interventions: Drug: malaria elimination using DP and low-dose primaquine

First Posted Date: 2013-06-07

Last Posted Date: 2020-08-28

Lead Sponsor: University of Oxford

Target Recruit Count: 8000

Registration Number: NCT01872702

Locations: 🇻🇳
Oxford University Clinical Research Unit - Vietnam, Ho Chi Minh city, Vietnam
🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand
🇰🇭
Pailin, Pailin, Cambodia

and more 2 locations

Binocular Vision in Monocular Pseudophakia

Not Applicable

Terminated

Conditions: Cataract

Interventions: Procedure: Cataract surgery

First Posted Date: 2013-06-07

Last Posted Date: 2019-06-13

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT01872000

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom
🇬🇧
Stoke Mandeville Hospital, Aylesbury, United Kingdom

Iron Status and Hypoxic Pulmonary Vascular Responses

Not Applicable

Completed

Conditions: Pulmonary Arterial Hypertension
Lung Hypoxia
Iron Deficiency

Interventions: Drug: Intravenous administration of ferric carboxymaltose
Other: Subacute hypoxic exposures

First Posted Date: 2013-05-06

Last Posted Date: 2016-05-06

Lead Sponsor: University of Oxford

Target Recruit Count: 31

Registration Number: NCT01847352

Locations: 🇬🇧
University of Oxford Department of Physiology, Anatomy and Genetics, Oxford, Oxfordshire, United Kingdom

TES for the Treatment of RP

Not Applicable

Completed

Conditions: Retinitis Pigmentosa

Interventions: Device: Transcorneal electrical stimulation

First Posted Date: 2013-05-06

Last Posted Date: 2018-11-13

Lead Sponsor: University of Oxford

Target Recruit Count: 14

Registration Number: NCT01847365

Locations: 🇬🇧
Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Phase 1

Completed

Conditions: Tuberculosis

Interventions: Biological: ChAdOx1 85A
Biological: MVA85A

First Posted Date: 2013-04-11

Last Posted Date: 2016-05-12

Lead Sponsor: University of Oxford

Target Recruit Count: 42

Registration Number: NCT01829490

Locations: 🇬🇧
The NIHR/ Wellcome Trust Clinical Research Facility, University of Birmingham, Birmingham, West Midlands, United Kingdom
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine , University of Oxford, Oxford, Oxfordshire, United Kingdom

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Phase 4

Completed

Conditions: Hepatitis B

First Posted Date: 2013-04-01

Last Posted Date: 2021-01-14

Lead Sponsor: University of Oxford

Target Recruit Count: 21

Registration Number: NCT01821547

Locations: 🇬🇧
Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford, Oxfordshire, United Kingdom

A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1

Phase 1

Completed

Conditions: Seasonal Influenza

Interventions: Biological: MVA NP+M1
Biological: ChAdOx1 NP+M1

First Posted Date: 2013-03-26

Last Posted Date: 2015-12-15

Lead Sponsor: University of Oxford

Target Recruit Count: 72

Registration Number: NCT01818362

Locations: 🇬🇧
Surrey Clinical Research Centre, University of Surrey, Guildford, United Kingdom
🇬🇧
NIHR Wellcome Trust Clinical Research Facility Southampton, Southampton, United Kingdom
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Phase Ia Study of ChAd63/MVA PvDBP

Phase 1

Completed

Conditions: Malaria
Plasmodium Vivax

Interventions: Biological: ChAd63 PvDBP 5 x 10^9
Biological: ChAd63 PvDBP 5 x 10^10
Biological: MVA PvDBP 1 x 10^8
Biological: MVA PvDBP 2 x 10^8

First Posted Date: 2013-03-21

Last Posted Date: 2017-05-08

Lead Sponsor: University of Oxford

Target Recruit Count: 24

Registration Number: NCT01816113

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

IMPROV (Improving the Radical Cure of Vivax Malaria)

Not Applicable

Completed

Conditions: Uncomplicated Vivax Malaria

Interventions: Drug: Placebo
Drug: Primaquine

First Posted Date: 2013-03-20

Last Posted Date: 2019-09-17

Lead Sponsor: University of Oxford

Target Recruit Count: 2388

Registration Number: NCT01814683

Locations: 🇪🇹
Arba Minch Hospital, Ārba Minch, Snnpr, Ethiopia
🇦🇫
Provincial Malaria & Leishmania control program (PMLCP) Nangarhar, Jalalabad, Nangarhar, Afghanistan
🇮🇩
Tanjong Leidong District Health Center, Medan, North Sumatra, Indonesia

and more 5 locations

Amiloride Clinical Trial In Optic Neuritis

Phase 2

Completed

Conditions: Optic Neuritis
Multiple Sclerosis

Interventions: Drug: Placebo
Drug: Amiloride

First Posted Date: 2013-03-01

Last Posted Date: 2018-05-17

Lead Sponsor: University of Oxford

Target Recruit Count: 46

Registration Number: NCT01802489

Locations: 🇬🇧
John Radcliffe Hospital, Oxford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy